Newly found pathway fuels cancer-driving proteins such as KRAS

· Science · United States

Researchers at The University of Texas MD Anderson Cancer Center report a previously unknown mechanism that helps cancer cells selectively produce proteins that drive tumor growth, such as KRAS, in common cancers. The findings suggest that targeting a specific enzyme may improve responses to targeted therapies; the item does not name the enzyme. KRAS is one of the most frequently mutated cancer genes, and KRAS-targeting drugs have only recently reached patients, so understanding how tumor cells keep supplying such proteins is directly relevant to resistance.

Why it matters：KRAS-targeted drugs are new and resistance is a major limit; a pathway controlling supply of the protein could shape the next generation of combination strategies.

Key points

  • The mechanism lets cancer cells selectively produce tumor-driving proteins.
  • Targeting a specific enzyme may improve responses to targeted therapies.

Sources (original reporting)

More stories from this day